- Filed
- Jun 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jun 13, 2025 | 136.62M sh |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $1.73M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $1.39M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $1.74M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $1.42M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $186.96K |
| Current Assets | Q2 2025 · Sep 30, 2024 | $410.19K |
| Total Assets | Q2 2025 · Mar 31, 2025 | $256.97K |
| Total Assets | Q2 2025 · Sep 30, 2024 | $493.81K |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 92.08M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 89.58M sh |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$61.12K |
| Stockholders Equity restated | Q2 2025 · Mar 31, 2024 | −$2.05M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | −$2.05M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | −$2.21M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $182.5K |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $197.25K |
| Net Income | Q2 2025 · Mar 31, 2024 | $235.82K |
| Net Income | Q2 2025 · Mar 31, 2024 | $387.47K |
| Net Income | Q2 2025 · Dec 31, 2023 | $151.65K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$574.05K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$644.61K |